Showing 1751-1760 of 2652 results for "".
- Sight Sciences: Two Year Study Results Show Sustained Reductions in IOP and Glaucoma Medication Use with Omni Treatmenthttps://modernod.com/news/sight-sciences-two-year-study-results-show-sustained-reductions-in-iop-and-glaucoma-medication-use-in-mild-moderate-poag-patients-treated-with-omni/2481630/Sight Sciences announced the publication of 2-year results of the ROMEO (Retrospective, Observational, Multicenter, Evaluation of OMNI) study in Clinical Ophthalmology. The longest multicenter study of the Omni Surgical System technology to date in both standalone and comb
- Alimera Acquires US Commercial Rights to Yutiqhttps://modernod.com/news/alimera-acquires-us-commercial-rights-to-yutiq/2481624/Alimera Sciences has acquired additional commercialization rights for Yutiq (fluocinolone acetonide intravitreal insert, 0.18mg) for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye from EyePoint Pharmaceuticals. Alimera now has exclusi
- EssilorLuxottica Unveils 4-Year Clinical Trial Results of its Essilor Stellest Lens athttps://modernod.com/news/essilorluxottica-unveils-4-year-clinical-trial-results-of-its-essilor-stellest-lens-at-arvo-at/2481572/EssilorLuxottica presented the 4-year clinical trial results of its Essilor Stellest lens for myopia control at the 2023 ARVO annual meeting in New Orleans. The findings show that Essilor Stellest lenses continue to exhibit strong efficacy in slowing myopia progression and axial ey
- Nidek Announces the Winners of the 3rd Annual Images of the Year Awardhttps://modernod.com/news/nidek-announces-the-winners-of-the-3rd-annual-images-of-the-year-award/2481521/Nidek has announced the winners of the 3rd Annual Images of the Year Award. While continuing the theme “invisible to visible,” this year’s contest highlighted how multiple imaging techniques of the Mirante Scanning Laser Ophthalmoscope (NIDEK) helps retina specialists visua
- GenSight Reports Topline Efficacy and Safety Results at 3 Years Post-Treatment with Lumevoqhttps://modernod.com/news/gensight-reports-topline-efficacy-and-safety-results-at-3-years-post-treatment-with-lumevoq/2481464/GenSight Biologics reported topline efficacy and safety results at 3 years post-treatment administration in the REFLECT phase 3 clinical trial with Lumevoq (lenadogene nolparvovec). The results show sustained efficacy and favorable safety for bilateral intravitreal injection of the gene
- GenSight Biologics Announces 1 Year Safety Data and Efficacy Signals from Phase 1/2 Trial of Optogenetic Treatment Candidate for RPhttps://modernod.com/news/gensight-biologics-announces-1-year-safety-data-and-efficacy-signals-from-phase-12-trial-of-optogenetic-treatment-candidate-for-rp/2481413/GenSight Biologics announced favorable safety data and encouraging efficacy signals at 1 year post-gene therapy administration for the PIONEER phase 1/2 clinical trial evaluating GS030 for the treatment of retinitis pigmentosa (RP) in 9 patients, with a follow-up up to 4 years (n=1).
- Orbis Announces 3-Year Partnership with Hoya Vision Carehttps://modernod.com/news/orbis-announces-3-year-partnership-with-hoya-vision-care/2481389/Eye care nonprofit Orbis International announced a renewed partnership with Hoya, which will commit its support over the next 3 years with a focus on helping school children get access to eye care in low- to middle-income countries, and on training eye care professionals around the world thr
- Three-Month Efficacy/Safety Data of SING IMT for AMD Publishedhttps://modernod.com/news/three-month-efficacysafety-data-of-sing-imt-for-amd-published/2481362/The first and largest single-surgeon case series to describe the short-term (3 months) safety and efficacy outcomes of the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT) in patients with severe to profound bilateral central vision impairment due to advanced A
- Lumibird Medical Launches Tango Reflex Neo YAG/SLT Laserhttps://modernod.com/news/lumibird-medical-launches-tango-reflex-neo-yagslt-laser/2481281/Lumibird Medical announced the launch of their next generation YAG/SLT laser, the Tango Reflex Neo, by Ellex. A fully integrated Q-switched Nd:YAG and frequency doubled Nd:YAG laser for anterior-segment YAG and glaucoma indications, Tango Reflex Neo features second-genera
- Helen Keller Intl and Partners Celebrate Vision Milestone, Screening 1 Million Students in New York Cityhttps://modernod.com/news/helen-keller-intl-and-partners-celebrate-vision-milestone-screening-1-million-students-in-new-york-city/2481208/On October 31, 2022, Helen Keller Intl will reach a major milestone: Its NY Vision team will provide free vision services to its one-millionth New York City student at the Academy for College Preparation and Career Exploration, a community school co-located in the Er